Teva fails to get immediate appeal in US antitrust case over Nuvigil
MLex Summary: Teva Pharmaceuticals was denied leave to immediately appeal an order on dismissal of US claims accusing it of blocking access to generic version of the wakefulness drug Nuvigil. “This...To view the full article, register now.
Already a subscriber? Click here to view full article